BrainCool AB (publ) (STO: BRAIN)

Market Cap	406.95M
Revenue (ttm)	40.67M
Net Income (ttm)	-57.58M
Shares Out	253.39M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,264
Open	1.598
Previous Close	1.600
Day's Range	1.532 - 1.618
52-Week Range	1.160 - 5.880
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About BrainCool AB

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an eas...

• Industry: Healthcare
• Sector: Healthcare
• Founded: 2010
• Employees: 24
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BRAIN

Financial Performance

In 2023, BrainCool AB's revenue was 27.40 million, a decrease of -8.81% compared to the previous year's 30.05 million. Losses were -61.28 million, 34.3% more than in 2022.